The EMA has a long history of providing guidance and support to European pharmaceutical companies. But how did the agency fare in 2020? In a June 2021 report, the European regulator shared details of its approach to managing key issues such as the COVID-19 pandemic and the threat of antimicrobial resistance.
In the document’s foreword, Christa Wirthumer-Hoche, Chair of the EMA Management Board, praised the agency for its ability to adapt to change. She said, “The pandemic started just as EMA was completing its relocation to the Netherlands and setting up in its new office in Amsterdam. The agency swiftly adapted its activities and processes to ensure a rapid response to the pandemic whilst maintaining their core activities to protect public health.”
To find out more about the EMA’s achievements in 2020, visit https://bit.ly/3zyQslC.
After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!
